Since active Wnt/β-catenin signaling is closely associated with CKD pathogenesis and DKK1 is an important secreted inhibitor of Wnt/β-catenin signaling, we compared the serum DKK1 levels between the predialysis patients with stages 4–5 CKD and the normal control subjects. This evidence concerns the gene DKK1 and chronic kidney disease.